0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
Sphingosine 1 Phosphate Receptor Modulators - Pipeline Insight, 2025 - Product Thumbnail Image

Sphingosine 1 Phosphate Receptor Modulators - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,500USDGBP
Oncolytic Virus Cancer Therapy - Pipeline Insight, 2025 - Product Thumbnail Image

Oncolytic Virus Cancer Therapy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 280 Pages
  • Global
From
EUR$5,000USDGBP
Anti-CD20 Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD20 Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
From
EUR$7,950USDGBP
Recurrent Anaplastic Astrocytomas - Pipeline Insight, 2025 - Product Thumbnail Image

Recurrent Anaplastic Astrocytomas - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
EUR$1,250USDGBP
Glioblastoma - Pipeline Insight, 2025 - Product Thumbnail Image

Glioblastoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 450 Pages
  • Global
From
EUR$5,000USDGBP
Gastric Neuroendocrine Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

Gastric Neuroendocrine Tumors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
TCR Therapy- Pipeline Insight, 2025 - Product Thumbnail Image

TCR Therapy- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 280 Pages
  • Global
From
EUR$3,000USDGBP
HER2-positive Gastric Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

HER2-positive Gastric Cancer- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
EUR$2,000USDGBP
T-Cell Acute Lymphoblastic Leukemia - Pipeline Insight, 2025 - Product Thumbnail Image

T-Cell Acute Lymphoblastic Leukemia - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,500USDGBP
From
EUR$1,250USDGBP
Lung Adenocarcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Lung Adenocarcinoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 90 Pages
  • Global
From
EUR$2,000USDGBP
Bevacizumab - Biosimilar Insight, 2025 - Product Thumbnail Image

Bevacizumab - Biosimilar Insight, 2025

  • Report
  • April 2025
  • 80 Pages
  • Global
From
EUR$2,000USDGBP
Castleman Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Castleman Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
EUR$1,250USDGBP
Central Nervous System Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Central Nervous System Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
EUR$1,250USDGBP
Atypical Teratoid Rhabdoid Tumors (ATRT)- Pipeline Insight, 2025 - Product Thumbnail Image

Atypical Teratoid Rhabdoid Tumors (ATRT)- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,250USDGBP
Cancer Therapy Related Diarrhea - Pipeline Insight, 2025 - Product Thumbnail Image

Cancer Therapy Related Diarrhea - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
EUR$1,250USDGBP
Basal Cell Nevus Syndrome (BCNS) - Pipeline Insight, 2025 - Product Thumbnail Image

Basal Cell Nevus Syndrome (BCNS) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,250USDGBP
Angioimmunoblastic T-cell Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Angioimmunoblastic T-cell Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,500USDGBP
DNA Topoisomerase I Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

DNA Topoisomerase I Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
EUR$2,000USDGBP
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more